A greater proportion of patients with severe, uncontrolled asthma had more significant clinical responses to tezepelumab than placebo, according to research published at the ATS 2022 […]
Nearly 13% of women born in the U.S. today will develop breast cancer at some point during their lives. Treatment for early-stage disease often includes breast-conserving […]
People seek third-trimester abortions for two main reasons: because they learn new information—such as about the health of the fetus—or because of barriers to abortion access, […]